Relmada Therapeutics
Develops NDV-01 for NMIBC and sepranolone for Prader-Willi syndrome.
$4.33
After-hours close−0.00 (−0.12%)
At close$4.34(−4.09%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 96.52%101.24M sharesInsiders 2.87%3.01M sharesOther 0.61%641.1K shares
Shares outstanding 104.89M · Float 90.42M · 86.2% free float
Institutions13F, as of Jun 30, 2026
131 holders · 101.24M shares · 48 new positions · 86 increased · 21 reduced · 23 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Jupiter Topco LLC | 11.16M | 10.64% | +11.16Mnew | Aug 14, 2026 |
| BlackRock, Inc. | 7.43M | 7.08% | +6.14M | Aug 7, 2026 |
| Squadron Capital Management LLC | 7.35M | 7.01% | −1.12M | Aug 14, 2026 |
| VR Adviser, LLC | 6.84M | 6.53% | +2.00M | Aug 14, 2026 |
| Spruce Street Capital LP | 6.39M | 6.09% | +129.2K | Aug 13, 2026 |
| Adage Capital Partners GP, L.L.C. | 4.76M | 4.54% | 0 | Aug 14, 2026 |
| Vanguard Capital Management LLC | 4.46M | 4.25% | +1.38M | Aug 13, 2026 |
| Jones Hill Capital LP | 3.66M | 3.48% | +3.31M | Aug 13, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Janus Henderson Group PLC | 10.10% | 7.44M | 13G | Feb 6, 2026 ↗ |
| Squadron Master Fund LP | 9.90% | 7.40M | 13G | Feb 17, 2026 ↗ |
| BlackRock, Inc. | 7.00% | 7.35M | 13G | Jul 29, 2026 ↗ |
| Venrock Healthcare Capital Partners III, L.P. | 6.20% | 6.51M | 13G | Jun 9, 2026 ↗ |
| Spruce Street Capital LP | 5.57% | 4.09M | 13G | Feb 17, 2026 ↗ |
| Commodore Capital LP | 5.10% | 5.51M | 13G | May 4, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Sergio Traversa | director, officer: Chief Executive Officer | 1.30M | 1.24% | Dec 16, 2025 |
| Maged Shenouda | officer: Chief Financial Officer | 800.0K | 0.76% | Dec 16, 2025 |
| Paul Edward Kelly | director, officer: Chief Operating Officer | 502.3K | 0.48% | Nov 6, 2025 |
| Chuck Ence | officer: CAO and COO | 403.9K | 0.39% | Nov 6, 2025 |
7 people have not refiled in the last 18 months (208.6K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Dec 15, 2025 | Maged Shenoudaofficer: Chief Financial Officer | Purchase | 11,665 | $4.12 | 800,000 |
| Dec 15, 2025 | Sergio Traversadirector, officer: Chief Executive Officer | Purchase | 27,500 | $4.12 | 1,300,000 |
| Nov 5, 2025 | Paul Edward Kellydirector, officer: Chief Operating Officer | Purchase | 90,000 | $2.20 | 502,295 |
| Nov 5, 2025 | Sergio Traversadirector, officer: Chief Executive Officer | Purchase | 272,500 | $2.20 | 1,272,500 |
| Nov 5, 2025 | Chuck Enceofficer: CAO and COO | Purchase | 136,000 | $2.20 | 403,931 |
| Nov 5, 2025 | Maged Shenoudaofficer: Chief Financial Officer | Purchase | 500,000 | $2.20 | 788,335 |
CongressHouse and Senate disclosures
Not reported.